These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38336188)

  • 1. Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing.
    Wang Y; Fu Q; Park SY; Lee YS; Park SY; Lee DY; Yoon S
    Biotechnol Adv; 2024; 71():108322. PubMed ID: 38336188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems.
    Lin YC; Lu M; Cai W; Hu WS
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):385. PubMed ID: 38896252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
    Collaco RF; Cao X; Trempe JP
    Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced ER protein processing gene expression increases rAAV yield and full capsid ratio in HEK293 cells.
    Fu Q; Wang Y; Qin J; Xie D; McNally D; Yoon S
    Appl Microbiol Biotechnol; 2024 Sep; 108(1):459. PubMed ID: 39230729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
    Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
    J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of an rAAV Producer Cell Line through Synthetic Biology.
    Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
    ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the production of recombinant adeno-associated virus in synthetic cell lines through systematic characterization.
    Lu M; Lee Z; Lin YC; Irfanullah I; Cai W; Hu WS
    Biotechnol Bioeng; 2024 Jan; 121(1):341-354. PubMed ID: 37749931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells.
    Cao TM; Chen D; Barnard GC; Shen A
    Biotechnol Bioeng; 2024 Jan; 121(1):395-402. PubMed ID: 37902721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
    Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
    Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells.
    Chung CH; Murphy CM; Wingate VP; Pavlicek JW; Nakashima R; Wei W; McCarty D; Rabinowitz J; Barton E
    Mol Ther Methods Clin Dev; 2023 Mar; 28():272-283. PubMed ID: 36819978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.
    Weinberg MS; Nicolson S; Bhatt AP; McLendon M; Li C; Samulski RJ
    J Virol; 2014 Nov; 88(21):12472-84. PubMed ID: 25142580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity.
    Lu M; Lin YC; Kuo HJ; Cai W; Ye Q; Zhao L; Hu WS
    Biotechnol J; 2024 Mar; 19(3):e2400051. PubMed ID: 38479988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.